ProstaGorx is the Ninth Innovus Pharma Product Approved in Canada to Date SAN DIEGO, June 04, 2018 (GLOBE NEWSWIRE) — Via OTC PR Wire – Innovus Pharmaceuticals, Inc. (“Innovus Pharma” or the “Company”) (OTCQB Venture Market:INNV), an emerging commercial-stage pharmaceutical company that delivers safe, innovative and effective over-the-counter medicine and consumer care products to improve men’s and women’s health and respiratory diseases, today announced the approval by Health Canada of its product ProstaGorx as a Natural Health Product (NPN # 80085717) forRead more
- American Rebel (OTCQB: AREB) Sales Grow 79% on Amazon
- GeoVax Comments on Recent Vaccine Development Study Funded by the Gates Foundation
- GrowLife Announces Rights Offering to Shareholders for Investment Opportunity for Marketing, Sales and Technology Expansion
- Mace Brand Announces Free Overnight Shipping of Mace Alert 911 to States Affected by Hurricane Florence
- Amazonas Florestal Ltd. Announced Today That the Company Has Appointed a New CFO and Director, Will be Renewing Its Lumber and Carbon Business in Brazil, and Has Completed Its Business Plan for the Colorado Plantations and Lab
SMALL CAP MARKET NEWS
We release small market news updates daily, 5 times a week! Always check back to get the inside scoop on what going on.
LEVERAGE OUR MASSIVE INVESTOR AUDIENCE!
Stock Investors · Accredited Investors · Hedge Fund InvestorsLearn More